Accelerating the future of human health
Accelagen is a leading global contract research organisation (CRO), co-creating meaningful outcomes that have a tangible impact on the future of human health.

Accelagen is a leading global contract research organisation (CRO). Our mission is to co-create meaningful outcomes that have a tangible impact on the future of human health.
We build a comprehensive picture of the end goal that aims to define your ambitions and key milestones, with a focus on what the product would look like on the shelf. From there, we work backwards to map the steps to achieve market approval, eliminating re- submissions and delays to approvals.
Through expert consultation and analysis, we develop a clear strategy that holds meaningful outcomes at the fore. We then carefully guide your product’s success at every stage of the journey - from initiation of human studies, through to final market authorisation and beyond.
The Accelagen difference
Accelagen’s work is underpinned by our unique reverse journey mapping approach. We build a comprehensive picture of the end goal that aims to define your ambitions and key milestones, with a focus on what the product would look like on the shelf. From there, we work backwards to map the steps to achieve market approval, eliminating re- submissions and delays to approvals.
Through expert consultation and analysis, we develop a clear strategy that holds meaningful outcomes at the fore. We then carefully guide your product’s success at every stage of the journey - from initiation of human studies, through to final market authorisation and beyond.
Providing accelerated and globally-recognised pathways to market

Lasting partnerships
True collaboration that is built on knowledge sharing and transparency. We prioritise understanding our partners’ end goal, opportunities and challenges, and deliver success through our unique reverse journey mapping approach.

Meaningful results
Our work centres on achieving meaningful outcomes for human health. Through the delivery of 100+ clinical trials across multiple countries and successfully gaining regulatory approval for new and exciting therapeutic options for patients, Accelagen’s reputation is built on our success rate and quality data.

Adaptable processes
Drawing on proven processes, we work with partners to personalise their success strategy. We focus on getting the right answers quickly to keep projects moving forward.
Our core values guide everything we do and shape how we work with our partners to create meaningful outcomes.

Clinical development

Clinical services that deliver meaningful outcomes
Accelagen delivers success across all stages of development, from the transition from preclinical to First in Human evaluation, through to Phase IV studies, and for large to small scale trial sizes. Our world-leading clinical development team customises trial designs to fulfil strategic objectives and achieve rapid progress.
We offer a large range of clinical services to deliver meaningful outcomes for the future of human health
Regulatory affairs

Gain efficient regulatory approval to bring your treatment of patients
We create effective pathways to product approval and future-proof plans for lifecycle management. Accelagen delivers holistic regulatory affairs strategies that span across regions, including the Asia-Pacific, North America and Europe.
Our expert team uncover the pathways that maximise the likelihood of regulatory approval, with a focus on patient safety and risk mitigation.





.png)

